Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
180.46
-5.70 (-3.06%)
Jul 20, 2026, 4:00 PM EDT - Market closed
Revolution Medicines Stock Forecast
Stock Price Forecast
According to 23 analysts polled by S&P Global, Revolution Medicines stock has a consensus rating of "Strong Buy" and an average price target of $200.5. The average 1-year stock price forecast is 11.10% higher than the current stock price, while the lowest is $151 (-16.32%) and the highest is $263 (+45.74%).
Price Target: $200.5 (+11.10%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Revolution Medicines stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 17 | 17 | 17 | 17 | 18 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 21 | 22 | 22 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $263 | Buy | Maintains | $263 | +45.74% | Jul 11, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jul 10, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $205 → $235 | Buy | Maintains | $205 → $235 | +30.22% | Jul 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $195 | Buy | Reiterates | $195 | +8.06% | Jul 6, 2026 |
| UBS | UBS | Buy Reiterates $175 → $220 | Buy | Reiterates | $175 → $220 | +21.91% | Jul 6, 2026 |
Financial Forecast
Revenue This Year
103.14M
Revenue Next Year
863.13M
from 103.14M
Increased by 736.85%
EPS This Year
-8.03
from -5.95
EPS Next Year
-5.73
from -8.03
EPS and Forward PE are based on non-GAAP adjusted numbers.